Telix Pharmaceuticals Limited (FWB:T3X) Financings

Telix Pharmaceuticals Limited

Financings

RaiseDate
At-the-market programme of new fully paid ordinary shares in the form of American Depository Shares (ADSs)
Announced: Morgan Stanley & Co. LLC +1
Dealers: Morgan Stanley & Co. LLC, William Blair & Company, L.L.C.
Use of proceeds: To facilitate greater access to the Company's securities on the Nasdaq stock exchange
Aug 20, 2026
1.50 per cent convertible notes due 2031
Made bigger: US$600M · J.P. Morgan Securities plc
Dealers: J.P. Morgan Securities plc (lead)
Use of proceeds: Refinancing of existing convertible bonds alongside a concurrent repurchase
Apr 15, 2026

Read by 6ix AI from the company's releases